These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 14068081)

  • 1. A QUANTITATIVE EXPRESSION FOR NITROGEN RETENTION WITH ANABOLIC STEROIDS. I. NORETHANDROLONE.
    METCALF W; GREENE HG
    Metabolism; 1963 Oct; 12():899-909. PubMed ID: 14068081
    [No Abstract]   [Full Text] [Related]  

  • 2. A QUANTITATIVE EXPRESSION FOR NITROGEN RETENTION WITH ANABOLIC STEROIDS. II. NORETHANDROLONE PROPIONATE; COMPARISON WITH TESTOSTERONE PROPIONATE AND NORETHANDROLONE.
    METCALF W; DARGAN EL; SUWANRAKS C; OHIN A
    Metabolism; 1963 Oct; 12():910-23. PubMed ID: 14068082
    [No Abstract]   [Full Text] [Related]  

  • 3. CLINICAL EVALUATION OF A NEW ANABOLIC AGENT 7-ALPHA,17-ALPHA-DIMETHYLTESTOSTERONE (BOLASTERONE).
    KORST DR; BOWERS CY; FLOKSTRA JH; MCMAHON FG
    Clin Pharmacol Ther; 1963; 4():734-9. PubMed ID: 14079251
    [No Abstract]   [Full Text] [Related]  

  • 4. A QUANTITATIVE EXPRESSION FOR NITROGEN RETENTION WITH ANABOLIC STEROIDS. 3. NORTESTOSTERONE DIPROPIONATE.
    METCALF W; ROACH J; OHIN A
    Metabolism; 1964 Jun; 13():539-46. PubMed ID: 14193985
    [No Abstract]   [Full Text] [Related]  

  • 5. EFFECTS OF ANABOLIC STEROIDS ON ALBUMIN METABOLISM.
    GROSSMAN J; YALOW AA
    J Clin Endocrinol Metab; 1965 May; 25():698-707. PubMed ID: 14313764
    [No Abstract]   [Full Text] [Related]  

  • 6. ANABOLIC STEROIDS: REVIEW WITH EMPHASIS ON USE IN OSTEOPOROSIS, SELECTED MALIGNANCIES, AND IN CORTICOSTEROID AND ACTH THERAPY.
    ROTH CH
    Am J Orthop; 1963 Oct; 5():296-301. PubMed ID: 14055773
    [No Abstract]   [Full Text] [Related]  

  • 7. [COMPARATIVE STUDY OF THE THERAPEUTIC ACTIVITY OF CERTAIN ANABOLIC STEROIDS WITH POTENTIALITY FOR BONE].
    ISEMEIN L; TABAU R
    Rhumatologie; 1964 Oct; 16():371-5. PubMed ID: 14225657
    [No Abstract]   [Full Text] [Related]  

  • 8. EVALUATION OF AN ANABOLIC AGENT, ETHYLESTRENOL, AND ITS EFFECT ON NITROGEN BALANCE IN THE PRESENCE OF A STEROID AGENT, DEXAMETHASONE.
    RUCHELMAN H; FORD RV
    Metabolism; 1963 Sep; 12():846-9. PubMed ID: 14062769
    [No Abstract]   [Full Text] [Related]  

  • 9. [METABOLIC CHAMBER STUDY OF A NEW TRIENE STEROID HORMONE].
    TREMOLIERES J; VELLUZ L
    Bull Acad Natl Med; 1965 Jan; 149():14-7. PubMed ID: 14306016
    [No Abstract]   [Full Text] [Related]  

  • 10. OBSERVATIONS ON THE NATURE OF THE UNDERLYING DISORDER AND THE OCCURRENCE OF ASSOCIATED PLASMA TRANSPORT ABNORMALITIES IN A PATIENT WITH AN IDIOPATHIC INCREASE IN THE PLASMA THYROXINE-BINDING GLOBULIN.
    INGBAR SH; WATERHOUSE C; CUSHMAN P
    J Clin Invest; 1964 Dec; 43(12):2266-71. PubMed ID: 14234822
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of an anabolic steroid, norethandrolone, on body weight and protein metabolism].
    SOULAIRAC A; SCHAUB C; MOREL J
    Ann Med Psychol (Paris); 1962 Feb; 120(1)():376-84. PubMed ID: 13915395
    [No Abstract]   [Full Text] [Related]  

  • 12. [URINARY ELIMINATION OF CALCIUM, PHOSPHORUS, NEURAMINIC ACID AND SEVERAL NITROGENOUS ELEMENTS BEFORE AND AFTER NORETHANDROLONE TREATMENT].
    CHATAGNON C; CHATAGNON PA
    Sem Ther; 1963 Dec; 39():637-40. PubMed ID: 14111258
    [No Abstract]   [Full Text] [Related]  

  • 13. Some quantitative aspects of nitrogen retention with norethandrolone. The ratio of experimental excretion to control excretion.
    GREENE HG; BLUMBERG H; METCALF W
    JAMA; 1963 Jan; 183():108-10. PubMed ID: 13950156
    [No Abstract]   [Full Text] [Related]  

  • 14. STUDIES ON THE BIOPHARMACOLOGY OF ANABOLIC AGENTS. I. THE EFFECT OF NORETHANDROLONE ON EXPERIMENTAL DENTAL CARIES IN THE RAT.
    SHAW SM; BAILEY HS; CHRISTIAN JE
    J Dent Res; 1964; 43():229-36. PubMed ID: 14128933
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of an anabolic agent (nilevar) on nitrogen and mineral metabolism in two patients with rheumatoid disease.
    HARRIS J; BLECHMAN W; YOUNG N; MALM O; VAUGHAN JH
    Arthritis Rheum; 1960 Aug; 3():341-49. PubMed ID: 14399962
    [No Abstract]   [Full Text] [Related]  

  • 16. BIOPHARMACOLOGY OF ANABOLIC AGENTS. II. RADIO-PHOSPHORUS UPTAKE IN MOLARS OF RATS FED NORETHANDROLONE AND PHOSPHORUS-ENRICHED CARIES-TEST DIETS.
    SHAW SM; BAILEY HS; CHRISTIAN JE
    J Pharm Sci; 1963 Dec; 52():1121-5. PubMed ID: 14088957
    [No Abstract]   [Full Text] [Related]  

  • 17. A QUANTITATIVE EXPRESSION FOR NITROGEN RETENTION WITH ANABOLIC STEROIDS. IV. OXANDROLONE.
    METCALF W; BLUMBERG H; ROACH J
    Metabolism; 1965 Jan; 14():59-66. PubMed ID: 14252343
    [No Abstract]   [Full Text] [Related]  

  • 18. NITROGEN METABOLISM IN RENAL FAILURE.
    ASHLEY BC
    Bull Postgrad Comm Med Univ Syd; 1964 May; 20():51-7. PubMed ID: 14170341
    [No Abstract]   [Full Text] [Related]  

  • 19. [RESEARCH ON THE BIOLOGICAL SUBSTRATES OF THE EFFECT OF A POWERFUL SYNTHETIC ANABOLIC STEROID NORETHANDROLONE].
    CHATAGNON C; CHATAGNON PA
    Ann Med Psychol (Paris); 1963 Nov; 121():612-8. PubMed ID: 14100708
    [No Abstract]   [Full Text] [Related]  

  • 20. Heart lesions associated with anabolic steroid abuse: comparison of post-mortem findings in athletes and norethandrolone-induced lesions in rabbits.
    Fanton L; Belhani D; Vaillant F; Tabib A; Gomez L; Descotes J; Dehina L; Bui-Xuan B; Malicier D; Timour Q
    Exp Toxicol Pathol; 2009 Jul; 61(4):317-23. PubMed ID: 19027274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.